BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines median Employee Total Annual Compensation (USD) ($)
DEF 14A Proxy Statement CEO Pay Ratio
Latest, FY2025
82,226
Period ended Dec 31, 2025
Change on a year earlier
-7.1%
88,543 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Median Employee Total Annual Compensation (USD) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 82,226 | -7.1% | Proxy Statement (DEF 14A) (filed 2026-04-28) ↗ |
| FY2024 | Dec 31, 2024 | 88,543 | +14.1% | Proxy Statement (DEF 14A) (filed 2025-04-07) ↗ |
| FY2023 | Dec 31, 2023 | 77,568 | -0.6% | Proxy Statement (DEF 14A) (filed 2024-04-26) ↗ |
| FY2022 | Dec 31, 2022 | 78,019 | +6.3% | Proxy Statement (DEF 14A) (filed 2023-04-27) ↗ |
| FY2021 | Dec 31, 2021 | 73,420 | -4.9% | Proxy Statement (DEF 14A) (filed 2022-04-29) ↗ |
| FY2020 | Dec 31, 2020 | 77,200 | – | Proxy Statement (DEF 14A) (filed 2021-04-30) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Median Employee Total Annual Compensation (USD) ($), annual FY2020–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/median_emp_comp
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.